Tax-driven share sale by Twist Bioscience (TWST) officer Dennis Cho disclosed

Rhea-AI Filing Summary

Twist Bioscience Corp officer Dennis Cho reported a mandated sale of 354 shares of Common Stock at $43.7864 per share to cover tax withholding on vesting Restricted Stock Units. After this sell-to-cover transaction, Cho directly holds 137,903 Twist Bioscience shares.

Insider Trade Summary

Net Seller: 354 shares ($15,500)

Net Sell 1 txn

Insider Cho Dennis

Role See Remarks

Sold 354 shs ($16K)

Type	Security	Shares	Price	Value
Sale	Common Stock	354	$43.7864	$16K

Holdings After Transaction: Common Stock — 137,903 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/24/2026 - 04:05 PM Learn about SEC filing dates

FAQ

What did Twist Bioscience (TWST) officer Dennis Cho report in this Form 4?

Dennis Cho reported selling 354 shares of Twist Bioscience Common Stock at $43.7864 per share. The transaction was a mandated sell-to-cover event for tax withholding tied to vesting Restricted Stock Units, not a discretionary open-market sale.

Why did Dennis Cho sell Twist Bioscience (TWST) shares in this filing?

The sale was required to cover tax withholding obligations from vesting Restricted Stock Units. Under Twist Bioscience’s equity incentive plans, these obligations are satisfied through a mandated “sell to cover” transaction, so the reported sale was not a discretionary trading decision.

How many Twist Bioscience (TWST) shares did Dennis Cho sell and at what price?

Dennis Cho sold 354 shares of Twist Bioscience Common Stock at an average price of $43.7864 per share. This single transaction was recorded as an open-market sale but designated specifically to satisfy tax withholding obligations on vested Restricted Stock Units.

How many Twist Bioscience (TWST) shares does Dennis Cho hold after this transaction?

Following the tax-related sale, Dennis Cho directly holds 137,903 shares of Twist Bioscience Common Stock. This shows the reported 354-share sell-to-cover transaction affected only a small portion of his overall direct share position in the company.

Does this Twist Bioscience (TWST) Form 4 indicate discretionary insider selling by Dennis Cho?

The Form 4 states the sale was mandated to cover tax withholding on vesting RSUs under the company’s equity incentive plans. Because it was a required “sell to cover” transaction, it does not represent a discretionary decision to reduce his investment exposure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cho Dennis

(Last) (First) (Middle)

C/O TWIST BIOSCIENCE CORPORATION

681 GATEWAY BLVD

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Twist Bioscience Corp [ TWST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/20/2026		S		354(1)	D	$43.7864	137,903	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Remarks:

Senior Vice President, Chief Legal Officer & Corporate Secretary

	/s/ Kendra Fox, as Attorney-in-Fact for Dennis Cho	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)